IP Library Granted Patent US 8,133,707
Granted Patent B2
US 8,133,707 · App. 11/333,072 · Granted Mar 13, 2012

Methods of preparing activated polymers having alpha nitrogen groups

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,133,707
App. No.
11/333,072
Granted
Mar 13, 2012
Kind
B2
Abstract

Methods for preparing substantially non-antigenic polymers having lone electron pair-containing moieties in high purity are disclosed. The polymers are useful as intermediates for synthesis of amine-based polymers and in the formation of activated polymers for conjugation with nucleophiles. Conjugates and methods of preparation and treatment with the conjugates are also disclosed. The resultant polymer-amines are of sufficient purity so that expensive and time consuming purification steps required for pharmaceutical grade polymers are avoided.

Claims (61)

1. A method of preparing a polymer having a lone electron pair-containing moiety thereon, comprising:

reacting a polymer of formula (I)

R 2 -R 1 -(L 1 ) n -LG  (I)

wherein

R 1 is a substantially non-antigenic polymer;

R 2 is a capping group, LG or LG-(L 1 ) n -;

L 1 is a bifunctional linker;

LG is a leaving group selected from the group consisting of

 wherein R 3 is methyl, halogen, nitro, fluoromethyl, difluoromethyl, trifluoromethyl, or substituted carboxyl; a multi-halogen substituted benzenesulfonyl;

mesylate; brosylate; tresylate, and nosylate; and

n is 0 or positive integer,

with a compound of Formula (III) in an aqueous base at a temperature of from about 45 to about 50° C. and for a reaction time of less than about 18 hours,

wherein the compound of Formula (III) is

wherein

Z is NR 7 ;

X is O, S or NR 8 ;

m is a positive integer;

R 4 is H;

R 5 , R 6 , R 7 and R 8 are independently selected from the group consisting of H, C 1-6 alkyls, C 3-12 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 heteroalkyls, substituted C 1-6 heteroalkyls, C 1-6 alkoxy, phenoxy and C 1-6 heteroalkoxy,

provided that R 4 and R 7 are both not H; and

the aqueous base is selected from the group consisting of NaOH, KOH, LiOH, Mg(OH) 2 , Ca(OH) 2 and mixtures thereof,

wherein

10 molar equivalent of compound of Formula (III) is employed for each equivalent of LG; and

the purity of the polymer having the lone electron pair-containing moiety thereon formed by said method is greater than 95%.

2. The method of claim 1 , wherein the reaction time is less than about 12 hours.

3. The method of claim 1 , wherein R 2 is methoxy.

4. The method of claim 3 , wherein LG is

5. The method of claim 1 , wherein X is O, m is 1, R 5 and R 6 are each H, and R 7 is methyl.

6. The method of claim 1 , wherein the compound of formula (III) is N-methyl-glycine (sarcosine).

7. The method of claim 1 , wherein R 1 is a polyalkylene oxide.

8. The method of claim 1 , wherein the polymer of Formula (I) is selected from the group consisting of

wherein

j is an integer from about 10 to about 340;

x is an integer from about 10 to about 2,300;

L 1 , L 2 and L 3 are bifunctional linkers; and

z is an integer from 1 to about 120.

9. The method of claim 7 , wherein said polyalkylene oxide is a polyethylene glycol of the formula: —CH 2 CH 2 —O—(CH 2 CH 2 O) x —CH 2 CH 2

wherein x is an integer from about 10 to about 2,300.

10. The method of claim 1 , wherein the substantially non-antigenic polymer has a weight average molecular weight from about 200 to about 100,000 Daltons.

11. The method of claim 10 , wherein the substantially non-antigenic polymer has a weight average molecular weight from about 2,000 to about 48,000 Daltons.

12. The method of claim 1 , wherein the polymer of formula (I) is:

wherein

R 2 is methoxy; and

R 1 is a polyalkylene oxide.

13. The method of claim 12 , wherein R 1 is a polyethylene glycol.

14. The method of claim 1 , wherein the aqueous base is NaOH.

15. The method of claim 1 , wherein the polymer having the lone electron pair-containing moiety thereon is

wherein

X is O or S;

m is 1;

n is 0 or 1;

R 5 and R 6 are independently selected from the group consisting of H, C 1-6 alkyls, C 3-12 branched alkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C 1-6 alkoxy, and phenoxy; and

R 7 is selected from the group consisting of C 1-6 alkyls, C 3-12 branchedalkyls, C 3-8 cycloalkyls, C 1-6 substituted alkyls, C 3-8 substituted cycloalkyls, aryls, and substituted aryls.

16. The method of claim 1 , further comprising reacting the polymer having the lone electron pair-containing moiety thereon with a compound having an activating group thereon to form an activated polymer having a lone electron pair-containing moiety thereon.

17. The method of claim 16 , wherein the activated polymer having the lone electron pair-containing moiety thereon is

18. The method of claim 16 , wherein the compound having the activating group thereon has a functional group capable of reacting with a nucleophile.

19. The method of claim 1 , wherein the purity of the polymer the polymer having the lone electron pair-containing moiety thereon formed by said method is greater than 98%.

20. The method of claim 17 , further comprising reacting

with asparaginase under conditions sufficient to form conjugates.

21. The method of claim 20 , wherein said asparaginase is derived from a recombinant source.

22. The method of claim 1 , wherein R 1 is a linear, branched or multi-armed polymer.

Assignments (4)
CHANGE OF ADDRESS Recorded Feb 3, 2014
From: BELROSE PHARMA INC.
To: BELROSE PHARMA INC.
Reel/Frame 032152/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2013
From: ENZON PHARMACEUTICALS, INC.
To: BELROSE PHARMA, INC.
Reel/Frame 030982/0692 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS CHANGE PREVIOUSLY RECORDED ON REEL 017487 FRAME 0181. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE IS CORRECT. Recorded Jan 26, 2012
From: ZHAO, HONG; WU, DECHUN
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 027606/0648 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2006
From: ZHAO, HONG; WU, DECHUN
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 017487/0181 →